Ten Days After Forager Proposal, Board Has Yet to Engage; Ongoing Delay Raises Stockholder Concerns

A major shareholder is pressuring for a buyout, but nothing is close to done.

What the company is saying

Forager Capital Management, holding approximately 13% of Repay Holdings Corporation (NASDAQ:RPAY), is publicly criticizing the Board for not engaging with its all-cash acquisition proposal. The core narrative is that Forager’s offer—at a 75% premium to the 30-day VWAP—delivers 'immediate and certain value' to shareholders, and that Board inaction is actively harming investor returns. Forager frames its proposal as both generous and urgent, repeatedly emphasizing the size of the premium and the supposed certainty of cash for shareholders. The announcement highlights the Board’s lack of substantive response, noting only the adoption of a poison pill and the unusual step of issuing a preliminary earnings release, which Forager characterizes as defensive maneuvers. The language is blunt, adversarial, and designed to rally other shareholders by suggesting the Board is not acting in their best interests. There is no attempt at balance or acknowledgment of possible Board rationale; the tone is accusatory and impatient. No notable individuals are named in the announcement, and the communication is institution-to-institution, not personality-driven. This fits a classic activist playbook: escalate public pressure, question Board motives, and frame the proposal as a litmus test for shareholder value orientation. Compared to typical company communications, this is a sharp departure—there is no attempt at consensus or dialogue, only a demand for action and a warning about lost value.

What the data suggests

The only hard numbers disclosed are Forager’s 13% ownership stake and the 75% premium to the 30-day VWAP in its acquisition proposal. There are no financial results, operational metrics, or historical performance data for Repay Holdings Corporation in the announcement. The absence of revenue, earnings, cash flow, or even a quoted VWAP figure means investors cannot independently verify the scale or context of the offer. There is also no information about the company’s recent financial trajectory, whether it is growing, shrinking, or stable. The Board’s actions—adopting a poison pill and issuing a preliminary earnings release—are mentioned, but without any supporting documentation or numbers. The gap between narrative and evidence is wide: Forager claims 'immediate and certain value,' but there is no signed deal, no Board engagement, and no timeline for execution. Prior targets or guidance are not referenced, and the quality of disclosure is poor—key metrics are missing, and the announcement is focused on agitation rather than transparency. An independent analyst, looking only at the numbers, would conclude that while the proposal is real, there is no basis to assess the underlying value of RPAY or the likelihood of the deal closing.

Analysis

The announcement is primarily a shareholder activism letter from Forager Capital Management, highlighting its 13% stake and a proposal to acquire Repay Holdings Corporation at a 75% premium. While the proposal itself is a concrete action, the announcement lacks evidence of any binding agreement or Board engagement, and no timeline for execution is provided. The language asserts that the proposal offers 'immediate and certain value,' but this is not substantiated by any signed deal or acceptance by the Board. The claim that delays reduce IRR is forward-looking and speculative, as no transaction is imminent. The capital outlay (all-cash acquisition at a significant premium) is large, but the benefits to shareholders remain hypothetical until the Board responds or a deal is executed. The gap between narrative and evidence is moderate: the proposal is real, but the outcome is uncertain and the benefits are not yet realised.

Risk flags

• ●Board resistance risk: The Board has not engaged with Forager’s proposal after ten days and has instead adopted a poison pill, signaling strong resistance. This matters because without Board cooperation, the deal is unlikely to proceed, and investors could see no value from the proposal.
• ●Execution risk: The proposal is not binding and there is no evidence of ongoing negotiations. Investors face the risk that the offer will never materialize into a transaction, leaving the current share price and company trajectory unchanged.
• ●Disclosure risk: The announcement contains no financial data about Repay Holdings Corporation—no revenue, earnings, or cash flow figures. This lack of transparency makes it impossible for investors to assess the company’s intrinsic value or the true attractiveness of the offer.
• ●Forward-looking hype: The majority of Forager’s claims are forward-looking and speculative, such as 'immediate and certain value' and warnings about IRR erosion. These are not supported by any concrete steps toward a deal, making them unreliable as a basis for investment decisions.
• ●Capital intensity risk: The proposal is for an all-cash acquisition at a 75% premium, a highly capital-intensive move. If the deal fails, the company could face further activist pressure or destabilization, and the share price could fall back to pre-offer levels.
• ●Pattern of defensive Board actions: The Board’s adoption of a poison pill and preliminary earnings release—without substantive engagement—suggests a pattern of prioritizing defense over negotiation. This could prolong uncertainty and reduce the likelihood of a near-term resolution.
• ●Timeline risk: With no disclosed schedule for engagement or deal closure, investors face the risk of indefinite delay. The longer the process drags on, the less likely it is that the premium will be realized, and the more likely that market conditions or Board composition could change.
• ●No notable institutional backers: The announcement does not mention any other large shareholders or institutional supporters joining Forager. Without broader support, the activist campaign may lack the leverage needed to force Board action.

Bottom line

For investors, this announcement signals that a major shareholder—Forager Capital Management—is attempting to force a sale of Repay Holdings Corporation at a substantial premium, but the Board is stonewalling. The narrative of 'immediate and certain value' is not credible at this stage, as there is no evidence of Board engagement, no signed agreement, and no disclosed timeline. The only hard facts are Forager’s 13% stake and the 75% premium offer; everything else is pressure tactics and forward-looking rhetoric. No notable institutional figures or additional shareholders are cited as supporting the campaign, which limits its immediate impact. For this assessment to change, the company would need to disclose either a binding agreement, a formal Board response, or detailed financials that allow investors to judge the offer’s true value. Key metrics to watch in the next reporting period include any Board communication, shareholder meeting outcomes, or signs of other large investors joining the activist push. At present, this is a situation to monitor, not act on—there is no actionable signal until the Board moves beyond defensive measures. The single most important takeaway: until the Board engages or a deal is signed, the premium is hypothetical and the status quo prevails.

Announcement summary

Forager Capital Management, the largest stockholder of Repay Holdings Corporation (NASDAQ: RPAY) with approximately 13% ownership, has issued a statement expressing surprise at the lack of substantive communication from the Board regarding its all-cash proposal to acquire the Company at a 75% premium to the 30-day VWAP. Forager criticizes the Board for only adopting a poison pill and issuing a preliminary earnings release, actions it views as defensive. The statement emphasizes that Forager's proposal offers immediate and certain value to stockholders and urges prompt engagement. Forager warns that delays by the Board prolong stockholders’ receipt of cash and reduce their IRR.

Disagree with this article?